Filing Details
- Accession Number:
- 0001209191-11-003104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-13 16:50:21
- Reporting Period:
- 2011-01-11
- Filing Date:
- 2011-01-13
- Accepted Time:
- 2011-01-13 16:50:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286208 | L Robert Roe | C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025 | President And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-01-11 | 50,000 | $1.50 | 178,890 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-01-11 | 50,000 | $4.14 | 128,890 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option | Disposition | 2011-01-11 | 50,000 | $0.00 | 50,000 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 650,000 | 2017-04-16 | No | 4 | M | Direct |
Footnotes
- The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.00 to $4.28 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exerciseable.
Billionaire Hedge Funds
